Astria Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-72.89	-51.83	-219.35	-37.3	-26.29	-25.87	-27.36	-36.06	-32.63	-21.88	Upgrade
Depreciation & Amortization	0	0	0	0	0	0.12	0.3	0.4	0.2	0.25	Upgrade
Share-Based Compensation	6.31	4.55	3.36	1.39	0	1.77	2.01	2.16	1.66	0.9	Upgrade
Other Operating Activities	-1.87	3.75	161.4	3.43	-0.28	0.52	-1.78	0.65	0.98	0.33	Upgrade
Operating Cash Flow	-68.45	-43.53	-30.15	-32.49	-26.57	-23.47	-26.84	-32.86	-29.79	-20.41	Upgrade
Capital Expenditures	-0.03	-0.09	-0.02	-0.03	-0.01	0.37	-0.03	-0.41	-0.42	-0.23	Upgrade
Acquisitions	0	0	6.47	0	0	0	0	0	0	0	Upgrade
Change in Investments	135.08	-167.04	-19	6.33	-4.07	-22.27	14.91	-15.08	0	0	Upgrade
Investing Cash Flow	135.05	-167.13	-12.56	6.3	-4.08	-21.91	14.88	-15.49	-0.42	-0.23	Upgrade
Share Issuance / Repurchase	88.4	144.72	104.28	40.86	25.62	47.14	8.06	12.5	61.84	0.12	Upgrade
Debt Issued / Paid	0	0	0	0	0	-2.85	-3.33	-3.33	4.16	4.72	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	12.33	-	Upgrade
Financing Cash Flow	88.4	144.72	104.28	40.86	25.62	44.3	4.73	9.16	78.33	4.83	Upgrade
Net Cash Flow	155.01	-65.94	61.58	14.68	-5.03	-1.08	-7.23	-39.18	48.11	-15.81	Upgrade
Free Cash Flow	-68.47	-43.62	-30.17	-32.52	-26.58	-23.1	-26.86	-33.27	-30.21	-20.64	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-5372.60%	-	-	-	Upgrade
Free Cash Flow Per Share	-2.27	-2.98	-3.38	-10.63	-14.24	-27.41	-74.34	-122.97	-225.42	-2917.47	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).